Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2014
05/27/2014US8735363 Preparation and application of heparin silver
05/27/2014US8735358 Methods for treating cancer by regulation of tumor necrosis factor-alpha
05/27/2014US8735354 Endothelium mimicking nanomatrix
05/27/2014US8735343 Product and process for liquefaction of mucus or sputum
05/27/2014US8735124 Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
05/27/2014US8735081 T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
05/27/2014US8734864 Methods for increasing human growth hormone levels
05/27/2014US8734855 Slow release magnesium composition and uses thereof
05/27/2014US8734853 HDL particles for delivery of nucleic acids
05/27/2014US8734851 Localized delivery of nucleic acid by polyelectrolyte assemblies
05/27/2014US8734850 Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
05/27/2014US8734849 Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form
05/27/2014US8734848 Hollow biodegradable nanospheres and nanoshells for delivery of therapeutic and/or imaging molecules
05/27/2014US8734847 Formulation of indomethacin
05/27/2014US8734846 Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles
05/27/2014US8734845 Diketopiperazine microparticles with defined specific surface areas
05/27/2014US8734844 Solid phase gold nanoparticle synthesis
05/27/2014US8734843 Medicament sustained-release particles and method for preparing the same
05/27/2014US8734842 Compositions for regenerating defective or absent myocardium
05/27/2014US8734841 Compositions for regenerating defective or absent myocardium
05/27/2014US8734840 Polynuclear microcapsules
05/27/2014US8734839 Liquid compositions for soft sustained-release capsules and method for production
05/27/2014US8734838 Adhesive containing polyisoprene, sis copolymer, and solid/liquid polyisobutylene for external use on skin
05/27/2014US8734836 Methods and compositions for applying pharmacologic agents to the ear
05/27/2014US8734834 Acrylic hydrogels with deprotonated amine groups that undergo volumetric expansion in response to changes in environmental pH
05/27/2014US8734833 Therapeutic foam
05/27/2014US8734832 Microemulsions with adsorbed macromolecules and microparticles
05/27/2014US8734830 Manufacturing method and apparatus of ultrafine particles having uniform particle size distribution
05/27/2014US8734828 Matrix-gel graft without cells
05/27/2014US8734823 Device including altered microorganisms, and methods and systems of use
05/27/2014US8734822 Composite shaped bodies and methods for their production and use
05/27/2014US8734819 Animal-repelling synthetic resin composition
05/27/2014US8734817 Hyaluronic acid based copolymers
05/27/2014US8734816 Porous nanoparticle supported lipid bilayer nanostructures
05/27/2014US8734810 Botulinum toxin treatments of neurological and neuropsychiatric disorders
05/27/2014US8734770 Methods and compositions for administration of TRPV1 agonists
05/27/2014US8734763 Compressed chewing gum tablet
05/27/2014US8734762 Perfluorocarbon nano-emulsion containing quantum dot nanoparticles and method for preparing the same
05/27/2014US8734430 Sustained release capsules
05/27/2014US8734429 Device, system and methods for the oral delivery of therapeutic compounds
05/27/2014US8734428 Insulin pump having selectable insulin absorption models
05/27/2014US8734316 Biomolecular wearable apparatus
05/27/2014CA2804124C Cannabis drug delivery and monitoring system
05/27/2014CA2738414C Extended release dosage form of ropinirole
05/27/2014CA2726861C Devices, formulations, and methods for delivery of multiple beneficial agents
05/27/2014CA2696632C High concentration local anesthetic formulations
05/27/2014CA2678424C Percutaneous administration device of bisoprolol
05/27/2014CA2666512C Soft capsules comprising palonosetron hydrochloride having improved stability and bioavailability
05/27/2014CA2658395C Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same
05/27/2014CA2656229C Improvements relating to biocidal compositions
05/27/2014CA2655044C Encapsulated labile compound compositions and methods of making the same
05/27/2014CA2624494C Orodispersible tablets of bitter active principles
05/27/2014CA2617920C Argatroban formulation comprising an acid as solubilizer
05/27/2014CA2609188C Apo-2 ligand/trail formulations
05/27/2014CA2588044C Ophthalmic compositions and methods for treating eyes
05/27/2014CA2552909C Pharmaceuticals for topical application in animals
05/27/2014CA2470511C Liquid composition of factor vii polypeptides
05/27/2014CA2460685C Cyclosporine analogue mixtures and their use as immunomodulating agents
05/27/2014CA2442080C A preparation for restenosis prevention
05/27/2014CA2440261C Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids
05/27/2014CA2375992C Method for controlled production of ultrafine microparticles and nanoparticles
05/22/2014WO2014078832A1 Implantable drug delivery compositions and methods of treatment thereof
05/22/2014WO2014078792A1 Flexible tissue matrix
05/22/2014WO2014078768A1 Leukocytes as delivery cells for imaging and disease therapy
05/22/2014WO2014078766A1 Aqueous liquid composition containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
05/22/2014WO2014078590A1 Composition containing an essential oil product and method for using such to maintain normal levels of testosterone
05/22/2014WO2014078581A1 Stable thermolysin hydrogel
05/22/2014WO2014078576A2 Oral transmucosal drug delivery system
05/22/2014WO2014078522A1 Materials and methods useful for treating glioblastoma
05/22/2014WO2014078486A1 Sustained-release dosage forms of ruxolitinib
05/22/2014WO2014078435A1 Compositions containing a biologically active material and a non-ordered inorganic oxide
05/22/2014WO2014078258A1 Process for making agglomerates using acoustic mixing technology
05/22/2014WO2014078162A1 Ectoparasiticidal methods and formulations
05/22/2014WO2014078080A1 Cross-linked collagen with a bound antimicrobial agent
05/22/2014WO2014077781A1 Method for eliciting an immune response to an immunogen
05/22/2014WO2014077778A1 Process and materials for medical applications
05/22/2014WO2014077712A1 Solid lipid nanoparticles of roxithromycin for hair loss or acne
05/22/2014WO2014077656A1 Injection composition containing polymer particulate of which initial drug burst is reduced and method for preparing same
05/22/2014WO2014077655A1 Sustained-release polymer microsphere containing anastrozole
05/22/2014WO2014077629A1 Biodegradable microbeads with improved anticancer drug adsorptivity, containing albumin and dextran sulfate, and preparation method therefor
05/22/2014WO2014077244A1 Transdermal absorption sheet, and manufacturing method for same
05/22/2014WO2014077243A1 Molding mold, and manufacturing method for transdermal absorption sheet
05/22/2014WO2014077242A1 Method for manufacturing transdermal-absorption sheet
05/22/2014WO2014076709A1 Liposomes for in-vivo delivery
05/22/2014WO2014076680A1 Solid dosage form comprising micronized cytisine
05/22/2014WO2014076642A1 Topical composition for the transepidermal or transdermal delivery of paracetamol
05/22/2014WO2014076639A1 Enemas
05/22/2014WO2014076632A1 A pharmaceutical composition containing an ace inhibitor and a calcium channel blocker
05/22/2014WO2014076568A2 Pharmaceutical compositions of cetp inhibitors
05/22/2014WO2014076432A1 Process for the production of a powdered dry emulsion containing at least one lipophilic active ingredient, intended for improving the bioavailability of said lipophilic active ingredient, and dry emulsion obtained by this process
05/22/2014WO2014076423A1 Quick-acting insulin formulation including a substituted anionic compound
05/22/2014WO2014076243A1 Optimization of nebulization properties of a solution or colloid
05/22/2014WO2014076203A1 Medicinal lozenge based on ibuprofen sodium dihydrate
05/22/2014WO2014076194A1 Effervescent tablet
05/22/2014WO2014076117A1 Orodispersible film compositions
05/22/2014WO2014076092A1 A proton pump inhibitor for use in a method of treating dermatological diseases in canine
05/22/2014WO2014076055A1 A method for preparing bioactive botanical compositions and the compositions made from said method
05/22/2014WO2014075692A1 Dispersible tablet
05/22/2014WO2014075554A1 Pharmaceutical composition containing sirolimus esterification and preparation method thereof
05/22/2014WO2014075185A1 Antimicrobial articles produced by additive manufacturing
1 ... 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 ... 2991